NO20040347L - Fast preparat inneholdende Bacillus-type ikke-patogene bakteriesporer - Google Patents

Fast preparat inneholdende Bacillus-type ikke-patogene bakteriesporer

Info

Publication number
NO20040347L
NO20040347L NO20040347A NO20040347A NO20040347L NO 20040347 L NO20040347 L NO 20040347L NO 20040347 A NO20040347 A NO 20040347A NO 20040347 A NO20040347 A NO 20040347A NO 20040347 L NO20040347 L NO 20040347L
Authority
NO
Norway
Prior art keywords
preparation containing
solid preparation
type non
bacterial spores
pathogenic bacterial
Prior art date
Application number
NO20040347A
Other languages
English (en)
Other versions
NO332656B1 (no
Inventor
Tiziano Prato
Original Assignee
Sanofi Synthelabo Otc Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Otc Spa filed Critical Sanofi Synthelabo Otc Spa
Publication of NO20040347L publication Critical patent/NO20040347L/no
Publication of NO332656B1 publication Critical patent/NO332656B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20040347A 2001-07-27 2004-01-26 Preparat av levende materiale som er sporer av ikke-patogene bakterier av Bacillus-slekten, og legemiddel som omfatter et slikt preparat. NO332656B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001632A ITMI20011632A1 (it) 2001-07-27 2001-07-27 Composizione solida contenente spore di batteri non patogeni del genere bacillus
PCT/EP2002/008384 WO2003011341A1 (fr) 2001-07-27 2002-07-26 Composition solide contenant des spores de bacteries non pathogenes du genre bacillus

Publications (2)

Publication Number Publication Date
NO20040347L true NO20040347L (no) 2004-03-26
NO332656B1 NO332656B1 (no) 2012-11-26

Family

ID=11448170

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040347A NO332656B1 (no) 2001-07-27 2004-01-26 Preparat av levende materiale som er sporer av ikke-patogene bakterier av Bacillus-slekten, og legemiddel som omfatter et slikt preparat.

Country Status (32)

Country Link
US (2) US8039006B2 (no)
EP (1) EP1429808B1 (no)
JP (1) JP4913986B2 (no)
KR (2) KR20090099022A (no)
CN (1) CN1323720C (no)
AT (1) ATE462448T1 (no)
AU (1) AU2002333278B2 (no)
BR (1) BRPI0211453B1 (no)
CA (1) CA2454389C (no)
CO (1) CO5560587A2 (no)
CY (1) CY1112608T1 (no)
DE (1) DE60235819D1 (no)
DK (1) DK1429808T3 (no)
EA (1) EA006847B1 (no)
ES (1) ES2356325T3 (no)
GE (2) GEP20063721B (no)
HK (1) HK1061644A1 (no)
HR (1) HRP20040066B1 (no)
HU (1) HU229652B1 (no)
IL (2) IL159807A0 (no)
IT (1) ITMI20011632A1 (no)
MA (1) MA27051A1 (no)
MX (1) MXPA04000835A (no)
NO (1) NO332656B1 (no)
NZ (1) NZ530743A (no)
PL (1) PL209647B1 (no)
PT (1) PT1429808E (no)
SI (1) SI1429808T1 (no)
TN (1) TNSN04018A1 (no)
UA (1) UA81225C2 (no)
WO (1) WO2003011341A1 (no)
ZA (1) ZA200400440B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599631B2 (en) 2001-01-26 2003-07-29 Nanogram Corporation Polymer-inorganic particle composites
KR100931948B1 (ko) * 2007-06-26 2009-12-15 영남대학교 산학협력단 제올라이트를 이용한 바실러스 포자의 열 안정성 향상 방법
BE1018018A6 (nl) 2008-02-28 2010-04-06 Gielen Cornelis Oplossing voor het biologisch reinigen van tandenborstels en bijhorende inrichting.
KR20110007168A (ko) * 2008-04-07 2011-01-21 바이엘 크롭사이언스 엘피 안정한 포자-함유 수성 제제
WO2009124707A2 (en) 2008-04-07 2009-10-15 Bayer Cropscience Ag Combinations of biological control agents and insecticides or fungicides
IT1393931B1 (it) * 2009-02-25 2012-05-17 Neuroscienze Pharmaness S C A R L Composizione di spore di batteri non patogeni
US20110244031A1 (en) * 2010-03-31 2011-10-06 Lifecycle Pharma A/S Porous tablets as carriers for liquid formulations
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP2953472A4 (en) * 2012-11-23 2017-03-01 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US10973861B2 (en) 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
CN105451561A (zh) 2013-02-04 2016-03-30 赛里斯治疗公司 组合物和方法
WO2014145958A2 (en) 2013-03-15 2014-09-18 Seres Health, Inc. Network-based microbial compositions and methods
MX367109B (es) 2013-11-25 2019-08-05 Seres Therapeutics Inc Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
WO2015095241A2 (en) 2013-12-16 2015-06-25 Seres Health, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
CN111212655A (zh) 2017-08-14 2020-05-29 赛里斯治疗公司 用于治疗胆汁淤积性疾病的组合物和方法
US11278578B2 (en) * 2018-09-02 2022-03-22 Sanzyme Biologics Private Limited Combination probiotic compositions and uses thereof
FR3125945A1 (fr) * 2021-08-03 2023-02-10 Setalg Composition pour protéger un microorganisme dans un environnement acide.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1061894A (en) 1963-03-01 1967-03-15 Lucien Nouvel Therapeutically active bacterial preparations
GB8425487D0 (en) * 1984-10-09 1984-11-14 Agricultural Genetics Co Strain of bacillus thuringiensis
DE3707160A1 (de) * 1987-03-06 1988-09-15 Hoechst Ag Bacillus polymyxa enthaltende mittel zur verabreichung an tiere
JPH0761255B2 (ja) * 1990-10-31 1995-07-05 旭化成工業株式会社 安定化芽胞形成生菌製剤の製造法
DE4404702A1 (de) 1994-02-15 1995-08-31 Hoechst Schering Agrevo Gmbh Wasserdispergierbare Granulate auf der Basis lebender Organismen
EP0746310B1 (en) * 1994-02-23 1998-11-18 BM Research A/S Controlled release composition
DK0765157T3 (da) * 1994-06-15 1999-10-25 Dumex Ltd As Pellets
DE4442255A1 (de) 1994-11-28 1996-05-30 Bayer Ag Schädlingsbekämpfungsmittel
JP3180886B2 (ja) * 1995-06-07 2001-06-25 旭化成株式会社 動物成長促進剤
EP1067945B1 (en) * 1998-04-01 2006-01-04 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
US6924133B1 (en) * 1999-10-01 2005-08-02 Novozymes A/S Spray dried enzyme product
US6387874B1 (en) * 2001-06-27 2002-05-14 Spartan Chemical Company, Inc. Cleaning composition containing an organic acid and a spore forming microbial composition

Also Published As

Publication number Publication date
US20120009167A1 (en) 2012-01-12
IL159807A0 (en) 2004-06-20
HRP20040066A2 (en) 2004-06-30
CA2454389C (fr) 2011-07-12
JP4913986B2 (ja) 2012-04-11
DK1429808T3 (da) 2010-07-19
HUP0402024A2 (hu) 2005-01-28
PL209647B1 (pl) 2011-09-30
US20040241772A1 (en) 2004-12-02
EP1429808A1 (fr) 2004-06-23
UA81225C2 (en) 2007-12-25
SI1429808T1 (sl) 2010-11-30
IL159807A (en) 2010-05-31
EA006847B1 (ru) 2006-04-28
PT1429808E (pt) 2010-06-23
ITMI20011632A0 (it) 2001-07-27
AU2002333278B2 (en) 2007-05-31
US8039006B2 (en) 2011-10-18
CN1558776A (zh) 2004-12-29
CN1323720C (zh) 2007-07-04
BR0211453A (pt) 2004-08-17
ITMI20011632A1 (it) 2003-01-27
ZA200400440B (en) 2005-03-30
ATE462448T1 (de) 2010-04-15
US8551498B2 (en) 2013-10-08
NZ530743A (en) 2005-08-26
KR100970787B1 (ko) 2010-07-16
GEP20063721B (en) 2006-01-10
HRP20040066B1 (en) 2012-02-29
HU229652B1 (en) 2014-03-28
ES2356325T3 (es) 2011-04-07
GEP20053721B (en) 2006-01-10
HK1061644A1 (en) 2004-09-30
PL366984A1 (en) 2005-02-07
MA27051A1 (fr) 2004-12-20
CA2454389A1 (fr) 2003-02-13
EA200400072A1 (ru) 2004-08-26
NO332656B1 (no) 2012-11-26
MXPA04000835A (es) 2004-05-14
CY1112608T1 (el) 2016-02-10
BRPI0211453B1 (pt) 2018-04-03
KR20090099022A (ko) 2009-09-18
DE60235819D1 (de) 2010-05-12
CO5560587A2 (es) 2005-09-30
WO2003011341A1 (fr) 2003-02-13
TNSN04018A1 (fr) 2006-06-01
KR20040032868A (ko) 2004-04-17
HUP0402024A3 (en) 2005-06-28
JP2004538311A (ja) 2004-12-24
EP1429808B1 (fr) 2010-03-31

Similar Documents

Publication Publication Date Title
NO20040347L (no) Fast preparat inneholdende Bacillus-type ikke-patogene bakteriesporer
BR0315209A (pt) Formulações nutritivas que contêm substâncias simbióticas
SE0102327D0 (sv) A novel engineered superantigen for human therapy
WO2007014372A3 (en) Compositions and methods for treating bacteria
BRPI0417826A (pt) bifidobactéria pseudolongum probiótica canina
ATE386534T1 (de) Orale darreichungsform enthaltend probiotische bakterien
BR0012992A (pt) Bifidobactérias que previnem a diarréia causada por bactérias patogênicas
BRPI0417793A (pt) bifidobactéria globosum probiótica canina
WO2005000878A3 (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
WO2006021001A3 (en) Amphiphilic polynorbornene derivatives and methods of using the same
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
ATE474582T1 (de) Pharmazeutische zusammensetzung enthaltend glucan aus mikroalgen
WO2005086669A3 (en) Hydrogenase deficient bacterial strains
ATE369145T1 (de) Aus einer bifidobakterien-kultur gewonnener immunomodulator und diesen enthaltende zusammensetzungen
AU2003230228A1 (en) Immunomodulating composition comprising a particulate fraction of bacterial mechanical lysates
RU2005104060A (ru) Способ профилактики микотоксикозов животных
WO2005034971A3 (en) Antiviral agent
WO2006066224A3 (en) Virulence targeted antibiotics
RU2007108834A (ru) Способ профилактики эндометритов коров
N’tcha et al. Research Article Antimicrobial Activity and Chemical Composition of (Kpètè-Kpètè): A Starter of Benin Traditional Beer Tchoukoutou
WO2006128044A3 (en) Compositions and methods for altering cellular functions
WO2003053959A8 (de) Heterocyclylaminocarbo nyluracile
RU2005111447A (ru) Способ отбора микроорганизмов для их включения в состав пробиотических препаратов
RU2007108843A (ru) Способ лечения эндометритов коров
AR045293A1 (es) Un promotor de crecimiento a base de la bacteria "bacillus megatherium" para aplicar en agricultura y el metodo para su desarrollo

Legal Events

Date Code Title Description
MK1K Patent expired